HealthCor Management’s Gilead Sciences GILD Stock Holding History

HealthCor Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-283,520	Closed	-$18.4M	–	52
2019 Q4	$18.4M	Sell	283,520 -199,410	-41%	-$13M	0.66%	41
2019 Q3	$30.6M	Sell	482,930 -280,370	-37%	-$18.3M	1.16%	33
2019 Q2	$51.6M	Buy	763,300 +139,810	+22%	+$9.2M	2%	22
2019 Q1	$40.5M	Buy	+623,490	New	+$41.4M	1.64%	25
2018 Q4	–	Sell	-132,870	Closed	-$10.3M	–	45
2018 Q3	$10.3M	Buy	+132,870	New	+$10M	0.34%	37
2018 Q2	–	Sell	-656,690	Closed	-$49.5M	–	57
2018 Q1	$49.5M	Buy	+656,690	New	+$52.2M	1.68%	24
2016 Q3	–	Sell	-270,680	Closed	-$22.6M	–	43
2016 Q2	$22.6M	Buy	+270,680	New	+$24M	1.23%	26
2015 Q2	–	Sell	-69,200	Closed	-$6.79M	–	65
2015 Q1	$6.79M	Sell	69,200 -1,180,800	-94%	-$120M	0.32%	51
2014 Q4	$118M	Buy	+1,250,000	New	+$129M	6.57%	2
2014 Q3	–	Sell	-447,600	Closed	-$37.1M	–	53
2014 Q2	$37.1M	Sell	447,600 -412,892	-48%	-$32.1M	1.86%	24
2014 Q1	$61M	Buy	860,492 +685,492	+392%	+$53.8M	3.67%	10
2013 Q4	$13.1M	Sell	175,000 -1,325,000	-88%	-$92.3M	0.8%	34
2013 Q3	$94.3M	Sell	1,500,000 -600,000	-29%	-$35.9M	5.05%	2
2013 Q2	$108M	Buy	+2,100,000	New	+$109M	6.51%	2

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

HealthCor Management's GILD Position: Q1 2020 in Review

HealthCor Management sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 283,520 shares — an estimated $18.4M sold.

HealthCor Management first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $118M in Q4 2014. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

HealthCor Management reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
HealthCor Management sold 283,520 Gilead Sciences shares in Q1 2020, an estimated $18.4M.
HealthCor Management first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
HealthCor Management's Gilead Sciences position peaked at $118M in Q4 2014.
1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on HealthCor Management's 13F filing for Q1 2020, filed 15 May 2020.